	Zinsaufwendungen Für Schuld		Datum
Agios Pharmaceuticals	USD 1.39B	85.53M	2025-09
ALKERMES	USD 4.65M	1.35M	2024-12
Amgen	USD 653M	32M	2025-12
Baxter International	USD 58M	14M	2025-09
BioCryst Pharmaceuticals	USD 24.45M	381K	2024-12
Biogen	USD 72.6M	12.6M	2025-06
Bristol-Myers Squibb	USD 432M	48M	2025-12
Cara Therapeutics	43.75M	4.8M	2025-06
Cipla	INR 140.3M	8.5M	2025-12
Dr.Reddys Laboratories	INR 944M	37M	2025-12
Eisai	JPY 1.43B	12M	2025-12
Eli Lilly	USD 114.7M	134.3M	2025-09
Esperion Therapeutics	USD 15.08M	1.36M	2024-09
Exelixis	USD 23.4M	3.9M	2023-09
Gilead Sciences	USD 255M	1000K	2025-12
GlaxoSmithKline	GBP 188M	21M	2025-12
Grifols	EUR 156.07M	31.46M	2025-09
Halozyme Therapeutics	USD 4.3M	98K	2025-09
Incyte	USD 582K	10K	2025-12
Ionis Pharmaceuticals	USD 18M	1000K	2025-09
Ironwood Pharmaceuticals	USD 8.74M	506K	2024-12
Karyopharm Therapeutics	USD 11.38M	2.43M	2024-09
MacroGenics	USD 3.34M	2.54M	2025-09
Merck	USD 412M	85M	2025-12
Nektar Therapeutics	USD 6.02M	420K	2024-09
Neurocrine Biosciences	USD 1.1M	0	2024-03
Novartis	USD 281M	8M	2025-09
Pfizer	USD 711M	59M	2025-12
Roche Holding	CHF 304M	7.5M	2025-06
Sarepta Therapeutics	USD 7.56M	2.33M	2025-09
Takeda	JPY 123.63B	40.49B	2025-12
Teva Pharmaceutical Industries	USD 220M	17M	2025-12
Xencor	USD 7.66M	578K	2025-09

Nektar Therapeutics Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.